Steven Cohen Teva Pharmaceutical Industries LTD Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 517,712 shares of TEVA stock, worth $11.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

517,712

Previous 1,319,217 60.76%

Holding current value

$11.8 Million

Previous $21.4 Million 56.48%

% of portfolio

0.03%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.81 - $18.96 $12.7 Million - $15.2 Million	-801,505 Reduced 60.76%	517,712 $9.33 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $4.64 Million - $6.32 Million	363,217 Added 37.99%	1,319,217 $21.4 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $5.95 Million - $8.05 Million	-558,006 Reduced 36.86%	956,000 $13.5 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $951,590 - $1.25 Million	-117,191 Reduced 7.18%	1,514,006 $15.8 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $5.16 Million - $7.38 Million	689,739 Added 73.26%	1,631,197 $16.6 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $6.78 Million - $8.92 Million	941,399 Added 1595591.5%	941,458 $7.09 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $493 - $670	59 New	59 $0
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $40 Million - $56.4 Million	5,424,079 Added 441.02%	6,653,979 $50 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $9.02 Million - $11.5 Million	1,229,900 New	1,229,900 $11.5 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $15.5 Million - $18.1 Million	-1,568,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $16.2 Million - $20.1 Million	1,568,700 New	1,568,700 $18.1 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $1.56 Million - $2 Million	-180,714 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $1.55 Million - $2.29 Million	180,714 New	180,714 $1.63 Million
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $178,980 - $293,824	-27,409 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$6.16 - $9.6 $89,437 - $139,382	14,519 Added 112.64%	27,409 $189,000
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $78,747 - $152,452	9,698 Added 303.82%	12,890 $119,000
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $49,731 - $63,871	3,192 New	3,192 $50,000
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $6.04 Million - $9.87 Million	-414,100 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $69.9 Million - $85.1 Million	-3,317,214 Reduced 88.9%	414,100 $8.92 Million
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $62.6 Million - $92.2 Million	3,731,314 New	3,731,314 $90.7 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $5.47 Million - $7.23 Million	-327,650 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $2.28 Million - $3.87 Million	202,650 Added 162.12%	327,650 $6.21 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $1.93 Million - $4.02 Million	125,000	125,000 $2.2 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account